GIROLAMI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.684
AS - Asia 3.375
EU - Europa 2.450
SA - Sud America 221
AF - Africa 67
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 12
Totale 25.823
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.656
SG - Singapore 1.480
CN - Cina 1.098
FI - Finlandia 509
VN - Vietnam 484
DE - Germania 399
SE - Svezia 397
FR - Francia 274
HK - Hong Kong 250
BR - Brasile 206
UA - Ucraina 182
GB - Regno Unito 176
IT - Italia 176
RU - Federazione Russa 135
PL - Polonia 87
CI - Costa d'Avorio 44
IE - Irlanda 33
IN - India 27
NL - Olanda 25
CA - Canada 20
AT - Austria 10
CZ - Repubblica Ceca 10
EU - Europa 10
AR - Argentina 9
AU - Australia 9
MA - Marocco 9
ES - Italia 6
TR - Turchia 6
BG - Bulgaria 5
EC - Ecuador 5
LT - Lituania 5
NZ - Nuova Zelanda 5
ZA - Sudafrica 5
BE - Belgio 4
CH - Svizzera 4
ET - Etiopia 4
LY - Libia 4
IQ - Iraq 3
IR - Iran 3
MX - Messico 3
RO - Romania 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AZ - Azerbaigian 2
BD - Bangladesh 2
JP - Giappone 2
NO - Norvegia 2
PA - Panama 2
PK - Pakistan 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
DK - Danimarca 1
EE - Estonia 1
HN - Honduras 1
HU - Ungheria 1
JO - Giordania 1
KG - Kirghizistan 1
KR - Corea 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PH - Filippine 1
PT - Portogallo 1
RS - Serbia 1
SN - Senegal 1
VE - Venezuela 1
Totale 25.823
Salva come PNG Salva come JPEG
Città #
Fairfield 3.199
Woodbridge 1.941
Houston 1.595
Chandler 1.560
Ashburn 1.328
Wilmington 1.172
Seattle 1.144
Ann Arbor 1.137
Cambridge 1.085
Jacksonville 991
Singapore 708
Princeton 541
Boardman 511
Dong Ket 480
San Diego 323
Beijing 276
Santa Clara 262
Hong Kong 250
Roxbury 224
Medford 210
Nanjing 209
Helsinki 182
Des Moines 173
Bytom 86
Hebei 65
Norwalk 62
Padova 62
Shenyang 61
Nanchang 60
London 51
Jiaxing 50
Abidjan 44
Changsha 43
Tianjin 42
Dublin 33
Redwood City 32
Guangzhou 28
Jinan 27
New York 27
Kilburn 18
São Paulo 16
Washington 16
Ogden 14
Indiana 12
Borås 11
Detroit 11
Dallas 10
Los Angeles 10
Zhengzhou 10
Chicago 9
Falkenstein 9
Hefei 9
Rockville 9
Tappahannock 9
Munich 8
Nuremberg 8
Chiswick 7
Falls Church 7
Hangzhou 7
Mestre 7
Rome 7
Shanghai 7
Brno 6
Curitiba 6
Frankfurt am Main 6
Madrid 6
Ningbo 6
Nürnberg 6
Southwark 6
Taizhou 6
Wandsworth 6
Amsterdam 5
Milan 5
Montreal 5
Muenster 5
Phoenix 5
Prescot 5
Rio de Janeiro 5
Sofia 5
Yuncheng 5
Addis Ababa 4
Belo Horizonte 4
Chengdu 4
Fuzhou 4
Kharkiv 4
Kunming 4
Lanzhou 4
Nutley 4
Porto Alegre 4
Rabat 4
San Francisco 4
Santo André 4
Taiyuan 4
The Dalles 4
Treviso 4
Tripoli 4
Wuhan 4
Acton 3
Auckland 3
Civitanova Marche 3
Totale 20.681
Salva come PNG Salva come JPEG
Nome #
1-Desamino-8-D-arginine vasopressin (DDAVP) infusion in type IIB von Willebrand's disease: shortening of bleeding time and induction of a variable pseudothrombocytopenia. 197
Activated protein C resistance in normal and pre-eclamptic pregnancies 146
Abnormal propeptide processing resulting in the presence of two abnormal species of protein C in plasma - Characterization of the dysfunctional protein C Padua(3) (Protein CR-1L/propeptide) 144
Venous thrombosis in von Willebrand disease as observed in one centre and as reported in the literature. 136
Type IIB von Willebrand Factor induces phospholipase A2 activation and cytosolic Ca2+ increase in platelets 133
Abnormalities of von Willebrand factor are also part of the prothrombotic state of Cushing's syndrome. 130
Aspirin and bleeding time 127
Abnormally large von Willebrand factor multimers in Henoch-Schönlein purpura. 126
FACTOR-VIII VONWILLEBRAND-FACTOR ABNORMALITIES DURING L-ASPARAGINASE TREATMENT IN PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIA 125
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand disease. 125
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis. 123
Selection of both normal and bleeding patients is indicated before desmopressin administration 121
Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP. 120
Bernard-Soulier Syndrome: diagnosis by ELISA method using monoclonal antibodies in 2 new unrelated patients 119
Myocardial infarction in two cousins heterozygous for ASN41HIS autosomal dominant variant of Bernard-Soulier syndrome. 119
Platelet serotonin and platelet aggregation in the differential diagnosis of thrombocytosis 118
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes 118
Multiple, relapsing thrombosis in a young man with primary thrombocytosis 115
Associated risk factors and arterial occlusions in patients with von Willebrand disease: Analysis of the literature and report of two cases 115
Spectrum of 5’UTR mutations in ANKRD26 gene in patients with inherited thrombocytopenia: c.-140C>G mutation is more frequent than expected 113
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors. 112
The significance of plasma and /or platelet activated products after apheresis procedures 112
Heparin induced thrombocytopenia: Prevalence in a large cohort of patients and confirmed role of PF4/heparin complex as the main antigen for antibodies 111
Conformation sensitive gel electrophoresis for detection of factor X gene mutations 110
A novel type I factor X variant (factor X Cys350Phe) due to loss of a disulfide bond in the catalytic domain 110
The biological inertia of coumarin-induced pre-factors (so called PIVKAs) 110
Acquired factor VIII:C inhibitor in a patient with Sjögren's syndrome: successful treatment with steroid and immunosuppressive therapy. 109
A new ELISA method for the detection of serum bindable anti-platelet antibodies (SPBIG). 109
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma 109
Plasma and platelet beta-thromboglobulin levels in patients with May-Hegglin anomaly 108
Heterozygous FXII deficiency is not associated with an increased incidence of thrombotic events: Results of a long term study 108
The significance of thrombocytosis in old age 107
"Pseudo homozygous" activated protein C resistance due to double heterozygous factor V defects (factor V Leiden mutation and type I quantitative factor V defect) associated with thrombosis: report of two cases belonging to two unrelated kindreds. 107
Thrombotic manifestations in plasminogen deficiency and in plasminogen abnormalities. 107
Complex History of the Discovery and Characterization of Congenital Factor X Deficiency. 107
The Dysprothrombinemias due to Arg596 Mutations: A Conundrum With No Bleeding Tendency and Venous Thrombosis due to Antithrombin Resistance 106
Abnormalities of von Willebrand factor in myeloproliferative disease: a relationship with bleeding diathesis. 105
Plasma fibrinolytic capacity in renal transplant recipients: Effect of steroid-free immunosuppression therapy. 105
Familial thrombocythemia and/or thrombocytosis: apparently a rare disorder 104
Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome 103
Normal and low molecular weight heparins: interaction with human platelets 103
Naturally occurring Arg-1 to Leu mutation in human protein C (protein C Padua(3)) resulting in an abnormal propeptide processing and in a molecule with discrepant functional activities 103
Thrombosis-free surgical procedures in severe (Homozygote) factor XII deficiency: report of four additional cases and literature review 102
Clinical and laboratory factors that affect the post-transfusion platelet increment 102
Severe arterial cerebral thrombosis in a patient with protein S deficiency (moderately reduced total and markedly reduced free protein S): a family study. 102
Prothrombin antigen levels in symptomatic and asymptomatic carriers of the 20210A prothrombin variant. 102
A highly polymorphic microsatellite in the factor V gene is an informative tool for the study of factor V-related disorders 101
Use of a radioimmunoassay for 5-hydroxytryptamine (5-HT) in thrombocytosis 101
Heterozygous protein-S deficiency: a study of a large kindred. 101
Pitfalls of protein C assays in patients with activated protein C resistance 100
Mild bleeding diathesis in a boy with combined severe haemophilia B (C(10400)-->T) and heterozygous factor V Leiden 100
A new global test for the evaluation of the protein C-protein S system. 100
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX) 100
Remission in hairy cell leukemia-variant following splenic radiotherapy alone 99
The relationship between defective heparin cofactor activities and thrombotic phenomena in AT III abnormalities. 99
Thrombotic and Hemorrhagic Conditions Due to a Gain of Function of Coagulation Proteins: A Special Type of Clotting Disorders 99
Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. 98
Potentiation of anticoagulant response to warfarin by sulphinpyrazone: a double-blind study in patients with prosthetic heart valves. 98
Age as the major predictive factor of long-term response to splenectomy in immune thrombocytopenic purpura 98
Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. 98
Clinical and laboratory expression of associated thrombophilic conditions (homozygous/heterozygous factor V Leiden mutation and heterozygous prothrombin variant 20210A) in an Italian family 97
A frequent factor XII gene mutation in Hageman trait. 97
Ischemic stroke in young patients with activated protein C resistance. A report of three cases belonging to three different kindreds. 97
Childhood stroke associated with familial protein S deficiency. 97
Abnormal collagen binding activity of 2A von Willebrand factor: evidence that the defect depends only on the lack of large multimers. 97
Thrombotic Events in Asymptomatic FXII Deficiency versus Symptomatic FXI Deficiency: Surprising Observations. 97
MARKED BUT TRANSITORY ELEVATION OF HEPATIC TRANSAMINASES AFTER SUBCUTANEOUS CALCIUM HEPARIN ADMINISTRATION 96
Thrombotic events in MYH9 gene-related autosomal macrothrombocytopenias (old May-Hegglin, Sebastian, Fechtner and Epstein syndromes). 96
Unexpected low prevalence of FVIII gene inversion in severe hemophilia A patients from north-eastern Italy 95
Inhibitory effect of prostacyclin and nitroprusside on type IIB von Willebrand factor-promoted platelet activation. 95
Normal pregnancy and delivery in essential thrombocythemia even without interferon therapy 95
Clinical significance of beta-thromboglobulin in patients with high platelet count 95
Partial gene deletion in a family with factor X deficiency. 95
FAILURE OF B-CELLS OF CHRONIC LYMPHOCYTIC-LEUKEMIA IN PRESENTING SOLUBLE AND ALLOANTIGENS 95
EDTA dependent pseudothrombocytopenia caused by antibodies against the cytoadhesive receptor of platelet gpIIB-IIIA. 94
Recovery from catastrophic antiphospholipid syndrome by a plasma exchange procedure: Report of four cases and review of the literature 93
Accuracy of two newly described D-dimer tests in patients with suspected deep venous thrombosis. 93
Do hemophilia A and von Willebrand disease protect against carotid atherosclerosis? A comparative study between coagulopathics and normal subjects by means of carotid echo-color Doppler scan. 92
Platelet aggregation induced by plasma from type IIB von Willebrand's disease patients is associated with an increase in cytosolic Ca2+ concentration. 92
The story of serum prothrombin conversion accelerator, proconvertin, stable factor, cothromboplastin, prothrombin accelerator or autoprothrombin I, and their subsequent merging into factor VII 92
A study of platelet function and morphology in a new family with May-Hegglin anomaly. 91
A simple ultrasound approach for detection of recurrent proximal-vein thrombosis. 91
A NEW MUTATION (ARG 251TRP) IN THE CA2+ BINDING SITE OF FACTOR XPROTEASE DOMAIN APPEARS BE THE RESPONSIBLE FOR THE DEFECT IN THE EXTRINSIC PATHWAY ACTIVATION OF FACTORX PADUA. 91
Thrombotic events in homozygotes with a proven or highly probable Arg304Gln Factor VII mutation (FVII Padua) 1): only limited replacement therapy is needed in case of surgery 91
Detection of B-cell monoclonality in fine needle aspiration by PCR analysis 91
Risk factors for thrombosis in patients with immune mediated heparin-induced thrombocytopenia 90
A protein S functional assay yields unsatisfactory results in patients with activated protein C resistance. 90
APC resistance, oral contraceptive therapy and deep vein thrombosis: settled and unsettled problems 89
Urokinase-type plasminogen activator release after DDAVP in von Willebrand disease: different behaviour of plasminogen activators according to the synthesis of von Willebrand factor. 89
Von Willebrand factor collagen binding activity in the diagnosis of von Willebrand disease: an alternative to ristocetin co-factor activity? 89
Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis 89
Discrepancies between clotting and amidolytic assay in congenital clotting disorders. 89
Discrepancies between von Willebrand factor multimeric composition and other tests in some von Willebrand's disease variants. 88
Type I Padua: a new variant of von Willebrand's disease. 88
A new congenital platelet abnormality characterized by spontaneous platelet aggregation, enhanced von Willebrand factor platelet interaction, and the presence of all von Willebrand factor multimers in plasma. 88
Myocardial infarction, other arterial thrombosis and invasive coronary procedures, in hemaophilia B: a critical evaluation of reported cases 88
The evaluation of factor VIII antigen by means of a simple slide test. 87
THE LONG TERM CLINICAL COURSE OF ACUTE DEEP VEIN THROMBOSIS OF THE ARM: PROSPECTIVE COHORT STUDY 87
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects. 87
A novel dysfunctional protein C (protein C Padua 2) associated with a thrombotic tendency: substitution of Cys for Arg-1 results in a strongly reduced affinity for binding of Ca++. 87
Totale 10.415
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.849
article - articoli 98.849
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 197.698
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020600 0 0 0 0 0 0 0 0 0 0 327 273
2020/20213.183 197 245 125 279 108 194 73 309 443 217 373 620
2021/20224.267 69 486 433 366 130 301 209 513 200 75 506 979
2022/20233.103 691 289 107 332 548 405 4 190 346 16 133 42
2023/20241.238 67 191 167 105 90 91 72 54 41 13 162 185
2024/20253.685 17 468 326 244 873 118 216 430 536 209 248 0
Totale 25.964